Family Planning Essential for Women With Rheumatic Diseases
An expert from the Division of Rheumatology and Clinical Immunology at the University of Pittsburgh discusses reproductive health and family planning in women with rheumatic diseases.
All articles by Tori Rodriguez, MA, LPC
Hypertension in Rheumatic Diseases: A Closer Look at Immune Mediators and Hormone Changes
A greater understanding of the mechanisms that promote hypertension in rheumatic diseases will provide insight into understanding primary hypertension.
Measuring Disease Activity in RA: What Are the Limitations With Current Models?
Research has shown that Disease Activity Scores are inflated as a result of pain reports that do not reflect actual disease activity in rheumatoid arthritis.
Cardiovascular Safety in Gout: Interpreting Data From the CARES Trial
Unexpected findings from the CARES trial have prompted discussion exploring the potential reasons for the observed discrepancy of increased cardiovascular mortality with febuxostat.
In the Spotlight: How Racism Affects the Healthcare Workforce
Racism is embedded in all US institutions, including medicine — so what steps are being taken to improve the well-being of the healthcare workforce?
Clinical Trials in Childhood-Onset Systemic Lupus Erythematosus: Next Steps and Future Directions
Access to medications for childhood-onset systemic lupus erythematosus is currently limited, partly because of a lack of high-quality evidence from clinical trials.
Inflammation: Is It the Link Between Rheumatoid Arthritis and Depression?
Both depression and rheumatoid arthritis contribute substantially to global disability, and these diseases often co-occur.
Managing Bisphosphonate Drug Holidays in Patients With Osteoporosis
Ongoing treatment with bisphosphonate therapy may not be needed to prevent future fractures in certain patients due to the sustained effect of the drug.
Renal Complications in Rheumatoid Arthritis: Evolution and Management
Rebecca L. Manno, MD, MHS, and Susan M. Goodman, MD, discuss renal manifestations in rheumatoid arthritis.
Using Rheumatoid Arthritis as a Model for Treatment Development in Dementia
If dementia is driven by inflammatory processes, patients with RA would be a model population to study, as the incidence of dementia is higher in these patients and it would be expected that dementia would progress more quickly.
Next post in Rheumatoid Arthritis Advisor
